INTRODUCTION
zation and cytokines as indicators (Dearman et al., 2000; Van et al., 2002) . Respiratory allergy is generally considered to be based on Th2 immune responses and dermal application of several respiratory sensitizers was found to induce such responses in mice (Dearman and Kimber, 2001) . In order to measure cytokines, draining lymph node cells and bronchoalveolar lavage fluid (BALF) may be used (Dearman et al., 2000; Van et al., 2002; Fukuyama et al., 2008) . For example, lymph node cells have been collected from chemical sensitized mice and cultured with or without concanavalin A, a stimulation factor of the production of IL-4, and shown by Dearman and co-workers to respond to several respiratory sensitizers by secreting Th2 cytokines (IL-4, IL-5 and IL-13) (Dearman et al., 2000; Dearman and Kimber, 2001) . Similarly, Th2 cytokines (IL-4, IL-5 and IL-13) are increased in BALF (Ban et al., 2006) . Therefore, Th2 cytokines are considered to be effective for identification of respiratory sensitizing potentials of chemicals. However, few systematic studies on various cytokine responses caused by chemical respiratory sensitizers in lungs were reported. In addition, most studies used a limited battery of test chemicals such as diisocyanates and acid anhydrides for analysis of BALF cytokines.
The objectives of this study were to identify effective cytokines as markers for detecting respiratory sensitizing potentials of chemicals. In the study, we analyzed nine BALF cytokines (G-CSF, IL-4, IL-5, IL-6, IL-12(p70), IL-13, IFN-γ, MCP-1 and TNF-α) and serum total IgE of dermally sensitized and intratracheally challenged mice using five known respiratory sensitizers and two contact sensitizers systematically. Our results provide useful information on the identification of respiratory sensitizers using BALF cytokines in animal models.
MATERIALS AND METHODS

Animals
Female BALB/c mice (6-7 weeks old) were purchased from Charles River (Kanagawa, Japan) and individually identified by marking with ink. They were housed in plastic cages containing wood-chips, and allowed food and water ad libitum. Before treatment, the mice were quarantined for 1 week and acclimatized in the room maintained on a 12-hr light-dark cycle. All of the animal experiments were conducted in accordance with current Japanese laws and the Guidelines for Proper Conduct of Animal Experiments (Science Council of Japan) and were approved by the Environmental Health Science laboratory IACUC of Sumitomo Chemical Co., Ltd.
Chemicals
Toluene diisocyanate (TDI) and acetone were purchased from Kanto Chemical (Tokyo, Japan); phthalic anhydride (PA), diphenylmethane-4,4'-diisocyanate (MDI), chloramine-T (CH), piperazine (PI), 2,4-dinitrochlorobenzene (DNCB), olive oil and diethyl ether from Nakalai Tesque (Kyoto, Japan); dimethyl sulfoxide (DMSO) from Dojindo Laboratories (Kumamoto, Japan); oxazolone (OXA) from Sigma-Aldrich (Tokyo, Japan); midazolam from Astellas Pharma (Tokyo, Japan); and medetomidine and butorphanol from Meiji Seika Kaisha (Tokyo, Japan). PA, MDI, TDI, DNCB and OXA were dissolved in 4:1 acetone:olive oil (AOO) for dermal application. PA was heated to aid solution in AOO using a water bath before application. CH and PI were dissolved in DMSO for dermal application. For intratracheal instillation, PA, CH, PI and OXA were dissolved in DMSO and mixed with olive oil, while MDI, TDI and DNCB were mixed with olive oil.
Dermal application and intratracheal instillation
For dermal application, 25% (w/v) PA, 2% (w/v) MDI, 1% (w/v) TDI, 10% (w/v) CH, 5% (w/v) PI, 1% (w/v) DNCB, 1% (w/v) OXA or vehicle (AOO or DMSO) were used (Table 1) . Fifty μl of chemical was applied on each shaved flank on days 0, 1, 6 and 7. On days 12, 13 and 14, 25 μl aliquots were applied on the dorsum of both ears. Non-sensitized mice were similarly treated dermally with solvents. On day 27, 50 μl of 0.05% (w/v) PA, 0.0001% (w/v) MDI, 0.001% (w/v) TDI, 0.00001% (w/v) CH, 0.00001% (w/v) PI, 0.01% (w/v) DNCB or 0.001% (w/v) OXA were intratracheally instilled into both sensitized and non-sensitized mice (Table 1) . Briefly, mice were anesthetized with a subcutaneously injection of midazolam (4 mg/kg), medetomidine (0.1 mg/kg) and butorphanol (5 mg/kg) in saline into the scruff of the neck. The trachea was then exposed surgically on the ventral side of the neck and intrapulumonary aerosolizer (PennCentury, PA, USA) was instilled via the mouth with monitoring of the exposed trachea for accurate instillation of chemicals. There were 8-10 mice per experimental group. The doses of dermal application were determined based on the previous studies Plitnick et al., 2003 Plitnick et al., , 2005 Farraj et al., 2007) and our unpublished data, which showed that a topical application of chemicals had little effect on mice skin. In brief, chemicals at various concentrations were applied on mice skin, and then the skin was observed 24 hr after application. The doses of intratracheal instillation were determined based on our pilot studies that chemicals at various concentrations were applied into lungs, and then the symptoms of mice were observed 24 hr after application. The doses with little effect on mice symptoms were selected for intratracheal instillation of chemicals.
Serum total IgE and BALF cytokines
Mice were anesthetized with inhalation of diethyl ether 24 hr after intratracheal instillation. Blood samples were collected from the abdominal aorta, and sera were stored frozen at -20°C until measurement of total IgE levels. Mice were sacrificed after the collection of blood samples and the trachea was exposed surgically on the ventral side of the neck. An incision was made on the upper trachea and a needle was inserted to allow BALF to be obtained using 1.0 ml of PBS (pH 7.3) containing 0.05 mM ethylenediaminetetraacetic acid (Dojindo Laboratories, Kumamoto, Japan) and 1 mg/ml bovine serum albumin (Wako Pure Chemical Industry, Osaka, Japan). BALF samples were centrifuged (800 × g, 10 min, 4°C) and the supernatants were frozen at -80°C until cytokine measurement. Serum total IgE and BALF cytokines (G-CSF, IL-4, IL-5, IL-6, IL-12(p70), IL-13, IFN-γ, MCP-1 and TNF-α) were measured by ELISA (Yamasa, Tokyo, Japan) and Bio-Plex (Bio-Rad, Tokyo, Japan), respectively, according to manufacturer's instructions. One-sided Student's T test was performed to assess whether the measurement values of sensitized groups were significantly greater than those of each control.
RESULTS
Serum total IgE
Mice were treated with chemicals as shown in Fig. 1 . Non-sensitized mice were treated dermally with solvents and challenged intratracheally with the respective test chemicals as solvent controls. Remarkable differences in symptoms were not observed between sensitized and non-sensitized mice 24 hr after intratracheal challenge. Sera were collected from dermally treated mice 24 hr after intratracheal challenge. Respiratory sensitizers, PA, MDI, TDI, CH and PI, showed statistically significant increases in total serum IgE compared with each control (Fig. 2) . As with these respiratory sensitizers, contact sensitizers DNCB and OXA caused increases in serum total IgE (Fig. 2) .
BALF cytokines
BALF was obtained 24 hr after intratracheal challenge (Fig. 1) . Nine cytokines (G-CSF, IL-4, IL-5, IL-6, IL-12(p70), IL-13, IFN-γ, MCP-1 and TNF-α) in BALF were measured by multiplex bead assays. Production of cytokines differed among chemicals, as shown in Fig. 3 . The reproducibility of the results was confirmed by additional studies for each chemical (data not shown).
The level of IL-4 showed a statistically significant increase in PA-sensitized mice compared with the control. However, the other chemicals did not cause any increase of IL-4 in sensitized mice. Intratracheal challenge with CH also resulted in elevated IL-4 in BALF, but was observed in both CH-sensitized and control mice. Thus, it was considered that the responses were not based on immune reactions. PA and CH, but not the other chemicals used in this study, caused statistically significant increases in the levels of IL-5 compared with controls. PA, TDI, CH, PI and DNCB induced statistically significant increases in the levels of IL-6. Elevation of IL-12(p70) levels was statistically significant with PA, MDI and TDI. Similarly 2 . Serum total IgE, measured by ELISA. *P < 0.05, **p < 0.01, ***p < 0.001 compared with each respective control group. n = 8-10 mice/group. Fig. 3 . BALF cytokines. IL-4, IL-5, IL-6, IL-12(p70), IL-13, IFN-γ, MCP-1, G-CSF and TNF-α were measured using a multiple cytokine assay system (Bio-Plex). *P < 0.05, **p < 0.01, ***p < 0.001 compared with each respective control group. n = 8-10 mice/group. IL-13 was found to be increased with PA, MDI, TDI and PI, and IFN-γ with PA, MDI, TDI and CH. Only PA and TDI caused statistically significant increase in MCP-1. All respiratory sensitizers tested in this study (PA, MDI, TDI, CH and PI) induced statistically significant increases in the levels of G-CSF compared with controls. In contrast, no such change was evident with contact sensitizers (DNCB and OXA). PA, MDI and TDI caused statistically significant increase in TNF-α.
DISCUSSION
In this study, five respiratory sensitizers (PA, MDI, TDI, CH and PI) induced statistically significant increases in total serum IgE (Fig. 2) , but so did both contact sensitizers, DNCB and OXA, similarly tested (Fig. 2) . Previous reports also showed that dermal application of not only respiratory sensitizers but additionally a contact sensitizer DNCB increased serum total IgE in mice (Ban and Hettich, 2001; Selgrade et al., 2006) . While serum IgE is considered to be one of the triggers of chemical-induced asthma (Holsapple et al., 2006; Arts and Kuper, 2007) , epidemiological studies have suggested that IgE independent responses may also be involved . The available data thus suggest that increase in total serum IgE is related to immune reactions, but itself can not be used as an indicator to discriminate between respiratory and contact sensitizers, at least in dermally sensitized mice.
Cytokine profiling of dermally sensitized mice consistently demonstrated their effectiveness as indicators of respiratory sensitizers (Dearman et al., 2000; Dearman and Kimber, 2001) . Dermal application of PA, MDI, TDI, CH and PI caused Th2 immune responses in mice Plitnick et al., 2003 Plitnick et al., , 2005 Farraj et al., 2007) . We therefore used these chemicals to analyze immune responses in lungs. The present study showed that all five induced statistically significant increases in BALF cytokines as a result of dermal sensitization and intratracheal challenge (Fig. 3) . However, differences in BALF cytokine profiles were observed, PA, MDI, TDI and PI for example causing statistically significant increases in IL-13, whereas no change was apparent with CH. Earlier work indicated skin exposures of respiratory sensitizers such as PA, MDI, TDI, CH and PI to induce Th2 responses featuring increased levels of IL-4, IL-5 and IL-13 in lymph nodes. The elevation of IL-4 levels was due to increases in IL-4 producing T cells in lymph nodes (Dearman et al., 2000; Dearman and Kimber, 2001 ). However, our results showed that IL-5 and IL-13 were increased in BALF by two and four examples, respectively, whereas IL-4 showed a statistically significant increase only in BALF of PA sensitized mice (Fig. 3) . These results imply that IL-4 producing T cells were increased in lymph nodes but not in lungs of mice sensitized with MDI, TDI, CH or PI. In addition to Th2 cytokines, production of Th1 cytokines like IL-12(p70) and IFN-γ was elevated by several of our respiratory sensitizers (Fig. 3) . It seems that the doses and frequencies of dermal application influence the Th1/Th2 balance and induce complex immune responses with Th1 and Th2 cytokines. Our results indicate that we may need to analyze a panel of several cytokines to assess immune responses.
Respiratory sensitizers increased Th2 cytokines in BALF (Fig. 3) , which showed that immune responses were caused in lungs. The present study showed that all five respiratory sensitizers induced statistically significant increase in G-CSF, but not DNCB and OXA (Fig. 3) . G-CSF functions as a stimulatory factor for neutrophils, which are reported to be involved in chemical-induced asthma in man (Park et al., 1999) . Increase in neutrophils was also observed in animal models with dermal sensitization (Matheson et al., 2005; Vanoirbeek et al., 2004) . Influx of eosinophils observed in human and animal models was also appears related to allergic asthma. However, our study showed that IL-5, which is closely related to the influx of eosinophils in lungs, was only increased by PA and CH (Fig. 3) . The animal model used in this study featured intratracheal challenge only once and BALF was collected 24 hr after the challenge, to detect immune responses at an early stage. A more sustained challenge may be required to generally induce influx of eosinophils. Thus, it was considered that neutrophils, rather than eosinophils, may be effective indicators in this topically intratracheal challenge model. Notably, G-CSF was increased by all respiratory sensitizers used in this study (Table. 2). The findings thus suggest that G-CSF and related cytokines could be effective to identify respiratory sensitizers in animal models. The measurement results of chemical-sensitized mice were compared with those of each control. + indicates a statistically significant increase (+ P < 0.05, ++ P < 0.01 and +++ P < 0.001); − indicates no change. n = 8-10 mice/group.
